These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23856046)

  • 21. A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.
    Selvam C; Oueslati N; Lemasson IA; Brabet I; Rigault D; Courtiol T; Cesarini S; Triballeau N; Bertrand HO; Goudet C; Pin JP; Acher FC
    J Med Chem; 2010 Apr; 53(7):2797-813. PubMed ID: 20218620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and structure-activity relationship of 1,3-cyclohexyl amide derivatives as novel mGluR5 negative allosteric modulators.
    Zhou H; Topiol SW; Grenon M; Jimenez HN; Uberti MA; Smith DG; Brodbeck RM; Chandrasena G; Pedersen H; Madsen JC; Doller D; Li G
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1398-406. PubMed ID: 23357634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
    Chen Y; Goudet C; Pin JP; Conn PJ
    Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition.
    Ellard JM; Madin A; Philps O; Hopkin M; Henderson S; Birch L; O'Connor D; Arai T; Takase K; Morgan L; Reynolds D; Talma S; Howley E; Powney B; Payne AH; Hall A; Gartlon JE; Dawson LA; Castro L; Atkinson PJ
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5792-6. PubMed ID: 26531152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent progress in the development of allosteric modulators of mGluR5.
    Rodriguez AL; Williams R
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype.
    Sams AG; Mikkelsen GK; Brodbeck RM; Pu X; Ritzén A
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3407-10. PubMed ID: 21531137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.
    Topiol S; Sabio M
    Bioorg Med Chem Lett; 2016 Jan; 26(2):484-494. PubMed ID: 26706173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and optimization of 4,5,6,7-tetrahydrooxazolo[4,5-c]pyridines as potent and orally-active metabotropic glutamate receptor 5 negative allosteric modulators.
    Hirose W; Kato Y; Natsutani I; Takata M; Kitaichi M; Imai S; Hayashi S; Arai Y; Hoshino K; Yoshida K
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4331-4335. PubMed ID: 28838696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA.
    Zhao Z; Wisnoski DD; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Wittman M; Ha SN; Schaffhauser H; Sur C; Pettibone DJ; Duggan ME; Conn PJ; Hartman GD; Lindsley CW
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1386-91. PubMed ID: 17210250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5.
    Burdi DF; Hunt R; Fan L; Hu T; Wang J; Guo Z; Huang Z; Wu C; Hardy L; Detheux M; Orsini MA; Quinton MS; Lew R; Spear K
    J Med Chem; 2010 Oct; 53(19):7107-18. PubMed ID: 20809633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: hit to lead studies.
    Gilbert AM; Bursavich MG; Lombardi S; Adedoyin A; Dwyer JM; Hughes Z; Kern JC; Khawaja X; Rosenzweig-Lipson S; Moore WJ; Neal SJ; Olsen M; Rizzo SJ; Springer D
    Bioorg Med Chem Lett; 2011 Jan; 21(1):195-9. PubMed ID: 21126874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate.
    Galambos J; Domány G; Nógrádi K; Wágner G; Keserű GM; Bobok A; Kolok S; Mikó-Bakk ML; Vastag M; Sághy K; Kóti J; Szakács Z; Béni Z; Gál K; Szombathelyi Z; Greiner I
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1249-52. PubMed ID: 26774652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators.
    Packiarajan M; Mazza Ferreira CG; Hong SP; White AD; Chandrasena G; Pu X; Brodbeck RM; Robichaud AJ
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5658-62. PubMed ID: 22832311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide.
    Barda DA; Wang ZQ; Britton TC; Henry SS; Jagdmann GE; Coleman DS; Johnson MP; Andis SL; Schoepp DD
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3099-102. PubMed ID: 15149652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain.
    O'Brien JA; Lemaire W; Wittmann M; Jacobson MA; Ha SN; Wisnoski DD; Lindsley CW; Schaffhauser HJ; Rowe B; Sur C; Duggan ME; Pettibone DJ; Conn PJ; Williams DL
    J Pharmacol Exp Ther; 2004 May; 309(2):568-77. PubMed ID: 14747613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs.
    Jiang L; Zhang X; Chen X; He Y; Qiao L; Zhang Y; Li G; Xiang Y
    Molecules; 2015 Jul; 20(7):12769-86. PubMed ID: 26184151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).
    Stauffer SR
    ACS Chem Neurosci; 2011 Aug; 2(8):450-70. PubMed ID: 22860171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications.
    Galambos J; Bielik A; Krasavin M; Orgován Z; Domány G; Nógrádi K; Wágner G; Balogh GT; Béni Z; Kóti J; Szakács Z; Bobok A; Kolok S; Mikó-Bakk ML; Vastag M; Sághy K; Laszy J; Halász AS; Balázs O; Gál K; Greiner I; Szombathelyi Z; Keserű GM
    J Med Chem; 2017 Mar; 60(6):2470-2484. PubMed ID: 28212015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators.
    Packiarajan M; Ferreira CG; Hong SP; White AD; Chandrasena G; Pu X; Brodbeck RM; Robichaud AJ
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6469-74. PubMed ID: 22975301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.